Invex Therapeutics Ltd (ASX:IXC)

Invex Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	7	5	15	37	47	88
Market Cap Growth	-18.52%	-70.00%	-59.60%	-21.43%	-46.04%	-
Enterprise Value	1	-2	-10	6	14	77
Last Close Price	0.09	0.06	0.05	0.13	0.16	0.33
PS Ratio	5.70	3.72	32.74	204.12	-	-
PB Ratio	1.28	0.79	0.71	1.31	1.48	3.60
P/TBV Ratio	1.28	0.79	0.71	1.31	1.48	3.60
EV/Sales Ratio	0.91	-	-	32.02	-	-
Asset Turnover	0.20	0.08	0.02	0.01	-	-
Quick Ratio	12.22	14.18	14.50	29.36	49.71	13.11
Current Ratio	12.22	14.18	14.50	29.36	49.71	13.11
Return on Equity (ROE)	2.14%	-12.20%	-31.18%	-13.05%	-8.09%	-18.75%
Return on Assets (ROA)	-1.20%	-9.22%	-20.43%	-8.10%	-5.16%	-10.47%
Return on Capital (ROIC)	-1.36%	-9.91%	-21.49%	-8.32%	-5.41%	-11.33%
Earnings Yield	1.65%	-36.41%	-51.56%	-10.63%	-4.82%	-3.83%
Buyback Yield / Dilution	-0.62%	-0.19%	-0.02%	-0.03%	-33.77%	-138.02%

Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.